Literature DB >> 25807442

Antioxidant potential of Aesculus hippocastanum extract and escin against reactive oxygen and nitrogen species.

J Vašková1, A Fejerčáková, G Mojžišová, L Vaško, P Patlevič.   

Abstract

OBJECTIVE: Antioxidant, anti-inflammatory and venoconstrictor properties have been attributed to extracts from Aesculus hippocastanum. These unusual and diverse properties may be possibly basically linked with ability to scavenge free radicals.
MATERIALS AND METHODS: The scavenging capacity of dry horse chestnut extract of and escin have been investigated in vitro against superoxide anion radicals, hydroxyl radicals, nitrites and peroxynitrite.
RESULTS: In general, the activity of the whole extract against superoxide radicals did not exceed 15% at pH 7.4, but the highest inhibition (46.11%) was recorded against hydroxyl radicals at a concentration of 100 µg.ml-1; however, the activity against other radicals was lower. Escin demonstrated a better ability to counteract nitric oxide oxidation products, nitrites. However, the efficiency of the whole extract completely disappeared as the concentration increased. Both extracts showed very low activity towards peroxynitrite. Escin was even able to induce peroxynitrite formation at the lower concentrations used.
CONCLUSIONS: Whole extract showed better antiradical properties compared to its main active ingredient, escin, probably due to potential synergistic interaction with a mixture of compounds present in the plant extract. These findings can be the basis of both the presentation of side-effects and the persistence of disease in spite of ongoing treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25807442

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice.

Authors:  Mahmoud Elshal; Sara H Hazem
Journal:  Inflammopharmacology       Date:  2022-09-05       Impact factor: 5.093

2.  β-Escin alleviates cobalt chloride-induced hypoxia-mediated apoptotic resistance and invasion via ROS-dependent HIF-1α/TGF-β/MMPs in A549 cells.

Authors:  Chermakani Paneerselvam; Sudhandiran Ganapasam
Journal:  Toxicol Res (Camb)       Date:  2020-05-08       Impact factor: 3.524

3.  Endothelia-Targeting Protection by Escin in Decompression Sickness Rats.

Authors:  Kun Zhang; Zhongxin Jiang; Xiaowei Ning; Xuhua Yu; Jiajun Xu; Peter Buzzacott; Weigang Xu
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

4.  Benefits of Escin for Decompression Sickness in Bama Pigs by Endothelial-Targeting Protection.

Authors:  Long Qing; Wentao Meng; Wei Zhang; Hong-Jie Yi; Kun Zhang; Dinesh K Ariyadewa; Wei-Gang Xu
Journal:  Front Physiol       Date:  2019-05-21       Impact factor: 4.566

Review 5.  Tissue Culture Response of Ornamental and Medicinal Aesculus Species-A Review.

Authors:  Snežana Zdravković-Korać; Jelena Milojević; Maja Belić; Dušica Ćalić
Journal:  Plants (Basel)       Date:  2022-01-20

6.  Aesculus hippocastanum L. Extract Does Not Induce Fibroblast to Myofibroblast Conversion but Increases Extracellular Matrix Production In Vitro Leading to Increased Wound Tensile Strength in Rats.

Authors:  Ivan Kováč; Nikola Melegová; Matúš Čoma; Peter Takáč; Katarína Kováčová; Martin Hollý; Ján Ďurkáč; Lukáš Urban; Miriam Gurbáľová; Emil Švajdlenka; Gabriela Mojžišová; Robert Zajíček; Pavol Szabo; Pavel Mučaji; Peter Gál
Journal:  Molecules       Date:  2020-04-22       Impact factor: 4.411

7.  Enzyme and Biological Activities of the Water Extracts from the Plants Aesculus hippocastanum, Olea europaea and Hypericum perforatum That Are Used as Folk Remedies in Turkey.

Authors:  Cengiz Sarikurkcu; Marcello Locatelli; Angela Tartaglia; Vincenzo Ferrone; Aleksandra M Juszczak; Mehmet Sabih Ozer; Bektas Tepe; Michał Tomczyk
Journal:  Molecules       Date:  2020-03-06       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.